GLYCOSYLATED HEMOGLOBIN AS PREDICTOR FOR LOWER EXTREMITY AMPUTATION IN DIABETIC PATIENTS

Khalid Usman, Salman Khan Kundi, Mohammad Iftakhar, Tahir Ghaffar Khattak

Abstract


Background: About 10% of patients with diabetes mellitus present with diabetic foot ulcers. The objective of the study was to determine the predictive role of HbA1c level on progression to lower limb amputation in diabetic patients.
Material & Methods: This was a case-control study conducted between January, 2014 and December, 2015. We collected a matched-pair data for patients with diabetic foot ulcers with or without amputation. Thirty-five patients from each group were statistically analyzed to see the predictive role of HbA1c for amputation.
Results: The mean age of all patients included was 56.06 ±4.6 years with 30(42.9%) males and 40(57.1%) females with a ratio of 1:1.3. Mean HbA1c was found to be 8.85 ±1.4%. A univariate logistic regression showed HbA1c as a predictor of amputation, sensitivity was 60%, specificity was 71.4%, positive predictive value 64.3% and negative predictive value 67.6%. For each unit decrease in HbA1c, the odds of reduction of amputation, reduced by 2.5 times (OR 0.40, 95% CI 0.24 to 0.66, p<0.001). The area under the curve was estimated at 77.9% (95% CI 66.9 to 88.9). The cut-off value of HbA1c for the above stated sensitivity and specificity was at 9.15%.
Conclusion: HbA1c can be effectively used as a laboratory parameter in evaluating diabetic foot ulcer patients and it can be employed as a target to reduce the amputation risk.

Keywords


Diabetic foot; Amputation; Glycosylated hemoglobin.

Full Text:

PDF

References


Bondor CI, Veresiu IA, Florea B, Vinik EJ, Vinik AI, Gavan NA. Epidemiology of diabetic foot ulcers and amputations in Romania: results of a cross-sectional quality of life questionnaire based survey. J Diabetes Res 2016;5439521.

Boyko EJ, Ahroni JH, Cohen V, Nelson KM, Heagerty PJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes care 2006;29:1202-7.

Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes care 1999;22:1036-42.

Brown ML, Tang W, Patel A, Baumhauer JF. Partial foot amputation in patients with diabetic foot ulcers. Foot Ankle Int 2012;33:707-16.

Davis WA, Norman PE, Bruce DG, Davis TM. Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study. Diabetologia 2006;49:2634-41.

Erqou S, Lee CT, Suffoletto M, Echouffo-Tcheugui JB, De Boer RA, Van Melle JP, et al. Association between glycated haemoglobin and the risk of congestive heart failure in diabetes mellitus: systematic review and meta-analysis. Eur J Heart Fail 2013;15:185-93.

Imran S, Ali R, Mahboob G. Frequency of lower extremity amputation in diabetics with reference to glycemic control and Wagner’s grades. J Coll Physicians Surg Pak 2006;16:124-7.

Janmohammadi N, Hasanjani Roshan MR, Rouhi M, Esmailnejad Ganji SM, Bahrami M, Moazezi Z. Management of diabetic foot ulcer in Babol, North of Iran: an experience on 520 cases. Caspian J Intern Med 2012;3:456-9.

Kayssi A, De Mestral C, Forbes TL, Roche-Nagle G. A Canadian population-based description of the indications for lower-extremity amputations and outcomes. Can J Surg 2016;59:99-106.

Mandal AK. In treating diabetes, what is important? Glucose levels or outcome measures? World J Diabetes 2015; 6:1243-5.

O’connor DJ, Gargiulo NJ, 3rd, Jang J. Hemoglobin A1c as a measure of disease severity and outcome in limb threatening ischemia. J Surg Res 2012;174:29-32.

Resnick HE, Valsania P, Phillips CL. Diabetes mellitus and nontraumatic lower extremity amputation in black and white Americans: the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, 1971-1992. Arch Intern Med 1999;159:2470-5.

Papanas N, Maltezos E. Glycated hemoglobin as a risk factor for lower extremity amputations in diabetes: success is counted sweetest. Int J Low Extrem Wounds 2015; 14:106-7.

Pemayun TG, Naibaho RM, Novitasari D, Amin N, Minuljo TT. Risk factors for lower extremity amputation in patients with diabetic foot ulcers: a hospital-based case-control study. Diabet Foot Ankle 2015;6:29629.

Rodrigues BT, Vangaveti VN, Malabu UH. Prevalence and risk factors for diabetic lower limb amputation: a clinic-based case control study. J Diabetes Res 2016;2016:5941957.

Yesil S, Akinci B, Yener S, Bayraktar F, Karabay O, Havitcioglu H, et al. Predictors of amputation in diabetics with foot ulcer: single center experience in a large Turkish cohort. Hormones (Athens) 2009;8:286-95.

Yang Y, Ostbye T, Tan SB, Abdul Salam ZH, Ong BC, Yang KS. Risk factors for lower extremity amputation among patients with diabetes in Singapore. J Diabetes Complications 2011;25:382-6.

Watts SA, Daly B, Anthony M, Mcdonald P, Khoury A, Dahar W. The effect of age, gender, risk level and glycosylated hemoglobin in predicting foot amputation in HMO patients with diabetes. J Am Acad Nurse Pract 2001;13:230-5.

Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Heymsfield SB, et al. HbA1c and lower-extremity amputation risk in low-income patients with diabetes. Diabetes care 2013;36:3591-8.

Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharrett AR. HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study. Diabetes care 2006;29:877-82.

Adler AI, Erqou S, Lima TA, Robinson AH. Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus-review and meta-analysis. Diabetologia 2010;53:840-9.

Tabur S, Eren MA, Celik Y, Dag OF, Sabuncu T, Sayiner ZA, et al. The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration. Wien Klin Wochenschr 2015;127:45-50.

Sarinnapakorn V, Sunthorntepwarakul T, Deerochanawong C, Niramitmahapanya S, Napartivaumnuay N. Prevalence of diabetic foot ulcers and risk classifications in type 2 diabetes mellitus patients at Rajavithi Hospital. J Med Assoc Thai 2016; 99 Suppl 2:S99-105.Dacis, con supio nondactum egeribus cles? Nihintiore quonsula nocut.


Refbacks

  • There are currently no refbacks.


© 2011 Gomal Journal of Medical Sciences